Cargando…
A case series on the efficacy and safety of a PD-1 inhibitor combined with antiangiogenic agents in the treatment of recurrent MSI-H endometrial cancer
BACKGROUND: Endometrial cancer (EC) is one of the most common gynecological malignancies in developed countries worldwide. The treatment of recurrent endometrial cancer is a very difficult problem in clinical work. Studies on patients with recurrent EC microsatellite instability-high (MSI-H) are ver...
Autores principales: | Song, Hualin, Du, Zhihua, Xiao, Huiting, Tian, Jing, Wang, Ke, Liu, Wenxin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10493622/ https://www.ncbi.nlm.nih.gov/pubmed/37701298 http://dx.doi.org/10.21037/gs-23-275 |
Ejemplares similares
-
The role of endometrial sampling for surveillance of recurrence in postmenopausal patients with medically inoperable stage I endometrial cancer
por: Carey-Love, Angelina, et al.
Publicado: (2020) -
The Effect and Safety of Anti-PD-1 Single/Combination Therapy in Refractory Thymic Carcinoma: A Case-Series Study
por: Jin, Wei, et al.
Publicado: (2020) -
Salvage treatment in recurrent endometrial cancer of the pelvis and peritoneal cavity
por: McAlarnen, Lindsey A., et al.
Publicado: (2019) -
Autofluorescence indexes as biomarkers for antiangiogenic loading
dose outcome in diabetic macular edema
por: Hernández Da Mota, Sergio E., et al.
Publicado: (2020) -
Serous endometrial intraepithelial carcinoma: a case series and literature review
por: Pathiraja, P, et al.
Publicado: (2013)